Spotlight
TLS in Tumors: What Lies Within

https://doi.org/10.1016/j.it.2015.12.001Get rights and content

The role of tertiary lymphoid structures (TLS) in cancer has recently been illustrated and revisited using mouse models. Joshi et al. describe regulatory T (Treg) cell infiltration and functional heterogeneity of TLS in lung tumors. Finkin et al. report that inflammation-associated TLS serve as niche for tumor progenitor cells, which may lead to recurrence in hepatocellular-carcinoma.

References (11)

There are more references available in the full text version of this article.

Cited by (19)

  • The Unmet Needs of the Diagnosis, Staging, and Treatment of Gastrointestinal Tumors

    2020, Seminars in Nuclear Medicine
    Citation Excerpt :

    The tumor contains all types of immune cells, including macrophages, dendritic cells, mast cells, natural killer cells, naive lymphocytes and memory lymphocytes, B cells and effector T cells.59 Immune cells may be positioned in the tumor interior, invasive margin or adjacent normal tissue, including tertiary lymphoid structures (TLS).60-66 The location, density, and functional orientation of various immune cell populations (referred to as "immune context" or immunological context.)

  • Immune-based identification of cancer patients at high risk of progression

    2018, Current Opinion in Immunology
    Citation Excerpt :

    The application of MCP-Counter to transcriptomic TCGA datasets also reveals a generally favorable impact of cytotoxic lymphocytes, whereas fibroblasts are usually related with a poorer survival [23••]. The presence of TLS that delineates generation and maintenance of effector memory T and B cell responses correlates with prolonged survival in most tumor types [34], with the exception of liver cancer where they are associated with higher recurrence rate when present in the cirrhotic tissue surrounding tumor nodules [35,36,37••]. Renal cell carcinoma (RCC) is a group of heterogeneous tumors with distinct genetic abnormalities.

  • Tumor-associated immune aggregates in oral cancer: Their cellular composition and potential prognostic significance

    2017, Medical Hypotheses
    Citation Excerpt :

    A small scaled study of OSCCs (n = 80) has found that the presence of TaIAs was a positive prognostic factor [11]. However, new evidence has revealed that the composition of these TaIAs has the potential to influence either tumor progression or tumor regression by being either pro-inflammatory (e.g. CD8+ cytotoxic T cells) or immunosuppressive (e.g., regulatory T cells) [8,21–23]. Therefore, in situ investigation of TaIA organization and density may enable the identification of patients with higher risks of recurrence and guide treatment decisions [12,24].

  • Physiology of chemokines in the cancer microenvironment

    2023, American Journal of Physiology - Cell Physiology
View all citing articles on Scopus
View full text